Metabolic Dysfunction in Pulmonary Arterial Hypertension

被引:0
作者
Tufik R. Assad
Anna R. Hemnes
机构
[1] Vanderbilt University Medical Center,Division of Pulmonary and Critical Care Medicine
来源
Current Hypertension Reports | 2015年 / 17卷
关键词
Pulmonary arterial hypertension; Insulin resistance; Aerobic glycolysis; BMPR2; PPARγ; Adiponectin; Apolipoprotein E; Right ventricular failure; Lipotoxicity; Metformin;
D O I
暂无
中图分类号
学科分类号
摘要
Previously considered a disease isolated to the pulmonary circulation, pulmonary arterial hypertension is now being recognized as a systemic disorder that is associated with significant metabolic dysfunction. Numerous animal models have demonstrated the development of pulmonary arterial hypertension following the onset of insulin resistance, indicating that insulin resistance may be causal. Recent publications highlighting alterations in aerobic glycolysis, fatty acid oxidation, and the tricarboxylic acid cycle in the pulmonary circulation and right ventricle have expanded our understanding of the complex pathobiology of this disease. By targeting these derangements in metabolism, numerous researchers are investigating noninvasive techniques to monitor disease activity and therapeutics that address the underlying metabolic condition. In the following review, we will explore pre-clinical and clinical studies investigating the metabolic dysfunction seen in pulmonary arterial hypertension.
引用
收藏
相关论文
共 406 条
[1]  
Simonneau G(2013)Updated clinical classification of pulmonary hypertension J Am Coll Cardiol 62 D34-D41
[2]  
Gatzoulis MA(2010)Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) Circulation 122 164-172
[3]  
Adatia I(2004)Pulmonary arterial hypertension N Engl J Med 351 1655-1665
[4]  
Celermajer D(2004)Pathologic assessment of vasculopathies in pulmonary hypertension J Am Coll Cardiol 43 25S-32S
[5]  
Denton C(2014)The genetics of pulmonary arterial hypertension Circ Res 115 189-202
[6]  
Ghofrani A(2007)Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation Circulation 115 1275-1284
[7]  
Benza RL(2009)Insulin resistance in pulmonary arterial hypertension Eur Res J 33 318-324
[8]  
Miller DP(2011)Unrecognized glucose intolerance is common in pulmonary arterial hypertension J Heart Lung Transplant : Off Pub Int Soc Heart Transplant 30 904-911
[9]  
Gomberg-Maitland M(2012)HbA1c in pulmonary arterial hypertension: a marker of prognostic relevance? J Heart Lung Transplant : Off Pub Int Soc Heart Transplant 31 1109-1114
[10]  
Frantz RP(2012)Metabolomic analysis of bone morphogenetic protein receptor type 2 mutations in human pulmonary endothelium reveals widespread metabolic reprogramming Pulm Circ 2 201-213